Y Intercept (Hong Kong) LTD Adma Biologics, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $1.78 Billion
- Q2 2024
A detailed history of Y Intercept (Hong Kong) LTD transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 34,055 shares of ADMA stock, worth $662,029. This represents 0.02% of its overall portfolio holdings.
Number of Shares
34,055Holding current value
$662,029% of portfolio
0.02%Shares
6 transactions
Others Institutions Holding ADMA
# of Institutions
265Shares Held
178MCall Options Held
535KPut Options Held
21.2K-
Black Rock Inc. New York, NY18.6MShares$362 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$282 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA13.2MShares$256 Million0.03% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL8.93MShares$174 Million0.03% of portfolio
-
State Street Corp Boston, MA8.06MShares$157 Million0.0% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.82B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...